TGTXTG Therapeutics, Inc. Stock Analysis

Exchange: NASDAQ | Sector: Healthcare | Industry: Biotechnology

Current Price: $33.45 (-0.83% today)

Market Cap: $5.38B

P/E (TTM): 10.80

Forward P/E (FY1): 24.20

EPS Growth: 64.7%

Analyst Upside: 16.6%

Relative Strength (RS%): 37

-28.0% from 52-week high

Back to Scanner

TGTX

NASDAQRS 37Score 48

TG Therapeutics, Inc.

HealthcareBiotechnology$5.38B2 setups passing
$33.45
-0.8% ($0.28)
-28.0% from 52W High
P/E (TTM)
10.80
Fwd P/E
24.20
PEG
Analyst Upside
+16.6%
EPS Growth
64.7%
Gross Margin
83.6%
ROE
101.1%
D/E
0.40
Div Yield
0.0%
Avg Volume
2.1M

Price Chart

Key Levels

SMA 200
$32.05
SMA 50
$30.00
Price
$33.45
52W High
$46.46
Target
$39.00

Setup Radar

2/8 passing
📈
CAN SLIMO'Neil
Near highs + RS ≥ 80
🎯
VCPMinervini
Within 25% high, RS ≥ 70, > 200 SMA
📊
Trend TemplateMinervini
> 50 & 200 SMA, RS ≥ 70, near high
🚀
Stage 2Weinstein
RS ≥ 60, > 200 SMA
📦
Darvas BoxDarvas
Near highs, > 200 SMA
Earnings MomentumGrowth
EPS growth ≥ 20%
🔍
PEG HunterLynch
PEG < 1.5, EPS growth ≥ 15%
🎪
Analyst UpsideConsensus
Target upside ≥ 15%, 1+ analyst